Adamis Pharmaceuticals
San Diego · Founded 2006
About Adamis Pharmaceuticals
Adamis Pharmaceuticals is a clinical-stage neuro-biotechnology company focused on the development and commercialization of potential blockbuster products for the treatment of a variety of neuro-based disorders with significant unmet medical needs. It commercializes products in various therapeutic areas, including allergy, opioid overdose, and respiratory and inflammatory diseases.
Company Facts
- Founded: 2006
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $75.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2023)
- Ticker: nasdaq:ADMP
- Website: adamispharmaceuticals.com
- Phone: +1 (858)-997-2400
Industries & Categories
Biopharma, Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/adamis-pharmaceuticals-199612 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.